TETRAPHASE PHARMACEUTICALS INC Research and Development Expense
TETRAPHASE PHARMACEUTICALS INC reported Research and Development Expense of $1.89 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2020-05-07
- TETRAPHASE PHARMACEUTICALS INC research and development expense for the quarter ending 2020-03-31 was $1.89M, a 71.90% decline year-over-year.
- TETRAPHASE PHARMACEUTICALS INC research and development expense for the quarter ending 2019-12-31 was $2.53M, a 76.36% decline year-over-year.
- TETRAPHASE PHARMACEUTICALS INC research and development expense for the quarter ending 2019-09-30 was $5.35M, a 54.15% decline year-over-year.
- TETRAPHASE PHARMACEUTICALS INC research and development expense for the quarter ending 2019-06-30 was $8.17M, a 43.17% decline year-over-year.
- TETRAPHASE PHARMACEUTICALS INC research and development expense for fiscal 2019 was $22.79M, a 58.48% decline from fiscal 2018.
- TETRAPHASE PHARMACEUTICALS INC research and development expense for fiscal 2018 was $54.88M, a 46.04% decline from fiscal 2017.
- TETRAPHASE PHARMACEUTICALS INC research and development expense for fiscal 2017 was $101.71M, a 59.50% increase from fiscal 2016.
- TETRAPHASE PHARMACEUTICALS INC research and development expense for fiscal 2016 was $63.76M, a 13.56% decline from fiscal 2015.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 81 month | Research and Development Expense 84 month | Research and Development Expense 87 month | Research and Development Expense 90 month | Research and Development Expense 93 month |
|---|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | $1.89M 10-Q · filed 2020-05-07 | $4.43M derived: sum of 2 quarters · filed 2020-05-07 | $9.78M derived: sum of 3 quarters · filed 2020-05-07 | $17.94M derived: sum of 4 quarters · filed 2020-05-07 | |||||
| 2019-12-31 | $2.53M 10-K · filed 2020-03-12 | $7.88M derived: sum of 2 quarters · filed 2020-03-12 | $16.05M derived: sum of 3 quarters · filed 2020-03-12 | $22.79M 10-K · filed 2020-03-12 | |||||
| 2019-09-30 | $5.35M 10-K · filed 2020-03-12 | $13.51M derived: sum of 2 quarters · filed 2020-03-12 | $20.25M 10-Q · filed 2019-11-12 | $30.97M derived: sum of 4 quarters · filed 2020-05-07 | |||||
| 2019-06-30 | $8.17M 10-K · filed 2020-03-12 | $14.90M 10-Q · filed 2019-08-08 | $25.62M derived: sum of 3 quarters · filed 2020-05-07 | $37.28M derived: sum of 4 quarters · filed 2020-05-07 | |||||
| 2019-03-31 | $6.74M 10-Q · filed 2020-05-07 | $17.45M derived: sum of 2 quarters · filed 2020-05-07 | $29.12M derived: sum of 3 quarters · filed 2020-05-07 | $43.49M derived: sum of 4 quarters · filed 2020-05-07 | |||||
| 2018-12-31 | $10.72M 10-K · filed 2020-03-12 | $22.38M derived: sum of 2 quarters · filed 2020-03-12 | $36.75M derived: sum of 3 quarters · filed 2020-03-12 | $54.88M 10-K · filed 2020-03-12 | |||||
| 2018-09-30 | $11.66M 10-K · filed 2020-03-12 | $26.04M derived: sum of 2 quarters · filed 2020-03-12 | $44.16M 10-Q · filed 2019-11-12 | $62.63M derived: sum of 4 quarters · filed 2020-03-12 | |||||
| 2018-06-30 | $14.37M 10-K · filed 2020-03-12 | $32.50M 10-Q · filed 2019-08-08 | $50.97M derived: sum of 3 quarters · filed 2020-03-12 | $79.74M derived: sum of 4 quarters · filed 2020-03-12 | |||||
| 2018-03-31 | $18.13M 10-K · filed 2020-03-12 | $36.60M derived: sum of 2 quarters · filed 2020-03-12 | $65.37M derived: sum of 3 quarters · filed 2020-03-12 | $93.89M derived: sum of 4 quarters · filed 2020-03-12 | |||||
| 2017-12-31 | $18.47M 10-K · filed 2019-03-15 | $47.25M derived: sum of 2 quarters · filed 2019-03-15 | $75.76M derived: sum of 3 quarters · filed 2019-03-15 | $101.71M 10-K · filed 2019-03-15 | |||||
| 2017-09-30 | $28.78M 10-K · filed 2019-03-15 | $57.29M derived: sum of 2 quarters · filed 2019-03-15 | $83.24M 10-Q · filed 2018-11-09 | $102.54M derived: sum of 4 quarters · filed 2019-03-15 | |||||
| 2017-06-30 | $28.51M 10-K · filed 2019-03-15 | $54.46M 10-Q · filed 2018-08-02 | $73.77M derived: sum of 3 quarters · filed 2019-03-15 | $90.95M derived: sum of 4 quarters · filed 2019-03-15 | |||||
| 2017-03-31 | $25.95M 10-K · filed 2019-03-15 | $45.25M derived: sum of 2 quarters · filed 2019-03-15 | $62.44M derived: sum of 3 quarters · filed 2019-03-15 | $76.19M derived: sum of 4 quarters · filed 2019-03-15 | |||||
| 2016-12-31 | $19.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $36.49M derived: sum of 2 quarters · filed 2018-03-06 | $50.24M derived: sum of 3 quarters · filed 2018-03-06 | $63.76M 10-K · filed 2018-03-06 | |||||
| 2016-09-30 | $17.19M 10-Q · filed 2017-11-01 | $30.94M derived: sum of 2 quarters · filed 2017-11-01 | $44.46M 10-Q · filed 2017-11-01 | $59.48M derived: sum of 4 quarters · filed 2018-03-06 | |||||
| 2016-06-30 | $13.75M 10-Q · filed 2017-08-02 | $27.27M 10-Q · filed 2017-08-02 | $42.28M derived: sum of 3 quarters · filed 2018-03-06 | $59.26M derived: sum of 4 quarters · filed 2018-03-06 | |||||
| 2016-03-31 | $13.52M 10-Q · filed 2017-05-08 | $28.54M derived: sum of 2 quarters · filed 2018-03-06 | $45.51M derived: sum of 3 quarters · filed 2018-03-06 | $68.42M derived: sum of 4 quarters · filed 2018-03-06 | |||||
| 2015-12-31 | $15.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $31.99M derived: sum of 2 quarters · filed 2018-03-06 | $54.90M derived: sum of 3 quarters · filed 2018-03-06 | $73.77M 10-K · filed 2018-03-06 | |||||
| 2015-09-30 | $16.97M 10-Q · filed 2016-11-03 | $39.88M derived: sum of 2 quarters · filed 2016-11-03 | $58.75M 10-Q · filed 2016-11-03 | $78.48M derived: sum of 4 quarters · filed 2017-03-13 | |||||
| 2015-06-30 | $22.91M 10-Q · filed 2016-08-04 | $41.78M 10-Q · filed 2016-08-04 | $61.51M derived: sum of 3 quarters · filed 2017-03-13 | $74.69M derived: sum of 4 quarters · filed 2017-03-13 | |||||
| 2015-03-31 | $18.87M 10-Q · filed 2016-05-04 | $38.60M derived: sum of 2 quarters · filed 2017-03-13 | $51.79M derived: sum of 3 quarters · filed 2017-03-13 | $68.30M derived: sum of 4 quarters · filed 2017-03-13 | |||||
| 2014-12-31 | $19.73M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $32.91M derived: sum of 2 quarters · filed 2017-03-13 | $49.43M derived: sum of 3 quarters · filed 2017-03-13 | $61.93M 10-K · filed 2017-03-13 | |||||
| 2014-09-30 | $13.19M 10-Q · filed 2015-11-02 | $29.70M derived: sum of 2 quarters · filed 2015-08-06 | $42.20M 10-Q · filed 2015-11-02 | $52.70M derived: sum of 4 quarters · filed 2016-02-25 | |||||
| 2014-06-30 | $16.51M 10-Q · filed 2015-08-06 | $29.02M 10-Q · filed 2015-08-06 | $39.51M derived: sum of 3 quarters · filed 2016-02-25 | $49.50M derived: sum of 4 quarters · filed 2016-02-25 | |||||
| 2014-03-31 | $12.50M 10-Q · filed 2015-05-07 | $23.00M derived: sum of 2 quarters · filed 2016-02-25 | $32.99M derived: sum of 3 quarters · filed 2016-02-25 | $39.91M derived: sum of 4 quarters · filed 2016-02-25 | $119.12M 10-Q · filed 2014-05-12 | ||||
| 2013-12-31 | $10.49M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $20.49M derived: sum of 2 quarters · filed 2016-02-25 | $27.41M derived: sum of 3 quarters · filed 2016-02-25 | $31.51M 10-K · filed 2016-02-25 | $106.61M 10-K · filed 2014-03-06 | ||||
| 2013-09-30 | $9.99M 10-Q · filed 2014-11-10 | $16.92M derived: sum of 2 quarters · filed 2014-11-10 | $21.01M 10-Q · filed 2014-11-10 | $25.63M derived: sum of 4 quarters · filed 2015-03-06 | $96.12M 10-Q · filed 2013-11-14 | ||||
| 2013-06-30 | $6.92M 10-Q · filed 2014-08-12 | $11.02M 10-Q · filed 2014-08-12 | $15.63M derived: sum of 3 quarters · filed 2015-03-06 | $20.05M derived: sum of 4 quarters · filed 2015-03-06 | $86.13M 10-Q · filed 2013-08-12 | ||||
| 2013-03-31 | $4.10M 10-Q · filed 2014-05-12 | $8.71M derived: sum of 2 quarters · filed 2015-03-06 | $13.13M derived: sum of 3 quarters · filed 2015-03-06 | $17.39M derived: sum of 4 quarters · filed 2015-03-06 | $79.20M 10-Q · filed 2013-05-13 | ||||
| 2012-12-31 | $4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06 | $9.03M derived: sum of 2 quarters · filed 2015-03-06 | $13.29M derived: sum of 3 quarters · filed 2015-03-06 | $17.29M 10-K · filed 2015-03-06 | |||||
| 2012-09-30 | $4.42M 10-Q · filed 2013-11-14 | $8.68M derived: sum of 2 quarters · filed 2013-11-14 | $12.68M 10-Q · filed 2013-11-14 | ||||||
| 2012-06-30 | $4.26M 10-Q · filed 2013-08-12 | $8.26M 10-Q · filed 2013-08-12 | |||||||
| 2012-03-31 | $4.00M 10-Q · filed 2013-05-13 | ||||||||
| 2011-12-31 | $17.74M 10-K · filed 2014-03-06 |